SURMOUNT-1 study - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Oxford Biomedica (LSE: OXB) delivers first EBITDA profit as revenue surges 33% and BMS CAR-T deal signals commercial maturity

Representative image of AI-driven central nervous system drug discovery, reflecting how Insilico Medicine expanded its Tenacia Biotechnology collaboration in a deal worth up to $94.75 million.

Insilico Medicine just doubled down on CNS with Tenacia. Here’s why that matters now.

Ola Electric’s #EndICEAge campaign slashes entry price to Rs 49,999 to reclaim lost ground in India’s electric two-wheeler market

NEXT plc (LON: NXT) delivers record profit of £1.16bn as international surge and brand portfolio drive 17% EPS growth

Read More

3 minute read

Pharma Industry News

This diabetes breakthrough drug slashes risk by 94%—discover how tirzepatide is transforming obesity treatment

Eli Lilly and Company (NYSE: LLY) has released compelling results from the SURMOUNT-1 study, which highlights that tirzepatide…

byPallavi Madhiraju

August 20, 2024

web analytics